Key Points Johnson & Johnson (NYSE: JNJ) just rewarded its shareholders again with a quarterly dividend. As a Dividend King, ...
Kelly’s departure “does not instill confidence” but shouldn’t affect the robot developer’s timeline for a regulatory ...
Rates of postoperative complications, readmissions and death were lower after robotic surgeries than laparoscopic and open ...
APACCEOLife science tools (publicly listed)NordicsPresident Life SciencesSpecialty chemicals (large-cap)UK & IrelandChief ...